MENU
Forex Education Symbols

(AMYT.L)
18.05 -0.2 (-1.1%) 02-23 16:30
Open: 18.035 Prev Close: 18.25
High: 18.34 Low: 17.82
Volume: 127,953 Market Cap: 50M
Year High: 29.5 Year Low: 16.7
Stock Technical Analysis
Overall       
Targets Six months: 23.47    One year: 25.11
Supports Support1: 17.82   Support2: 14.83
Resistances Resistance1: 20.09    Resistance2: 21.50 
Pivot Point 18.92 
Moving Averages MA(5): 18.31      MA(20): 19.18 

MA(100): 19.90      MA(250): 21.405 
MACD MACD(12,26): -0.46      Signal(12,26,9): -0.35 
Stochastic Oscillator %K(14,3): 10.25      %D(3): 8.94 
RSI RSI(14): 13.18 
52-Week High: 29.50  Low: 16.70  Change(%): -3.7
Average Volume(K) 3-Month: 21757  10-Days: 12539.779297
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
AMYT.L has closed above bottom band by 9.3%. Bollinger Bands are 0.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Amryt Pharma inks fourth distribution deal in three months for key product
Tue, 30 Jan 2018 07:27:59 GMT

Amryt Pharma makes senior hire
Wed, 20 Dec 2017 08:14:53 GMT

Amryt Pharma raising €15mln to fund development of breakthrough skin treatment
Thu, 21 Sep 2017 06:53:47 GMT

Amryt Pharma inks exclusive Saudi Arabian distribution agreement for its ...
Mon, 13 Nov 2017 07:41:15 GMT

Amryt Pharma drug exceeds expectations; potential market bigger than anticipated
Mon, 04 Sep 2017 07:20:07 GMT

Is Amryt Pharma plc (LON:AMYT) A Financially Sound Company?
Fri, 12 Jan 2018 12:00:00 GMT

Stoxline Canada

Stock Chart London

Option Calculator

Financials
EPS
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M) 2.71
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Valuation
P/E -0.63
P/E Growth Ratio
P/BV
P/S
P/CF